Latest news with #AdityaAgarwal
Fashion Network
15-05-2025
- Business
- Fashion Network
Be Clinical raises Rs 2 crore in seed funding round led by Titan Capital
Be Clinical, a science-led skincare brand has raised Rs 2 crore ($234,439) in a seed funding round led by Titan Capital, with additional backing from angel investor Aditya Agarwal. The brand will utilise the capital to bring manufacturing in-house, improving operational workflows, and safeguarding the brand's proprietary formulations. Additionally, the brand plans to expand into new segments within the anti-ageing category. Commenting on the funding, Hemangi Dhir, founder of Be Clinical in a statement said, 'Securing this investment is a strong validation of our vision. Anti-ageing has often been treated as an afterthought, but at Be Clinical, it's our primary focus. We're building a brand that addresses a real and growing need.' A spokesperson from Titan Capital added, 'We invested in Be Clinical because it sits at the intersection of science and self-care. What truly stood out was the founder's deep understanding of the modern skincare consumer—not just what they buy, but why.' Founded by Hemangi Dhir, Be Clinical operates through a direct-to-consumer model across India.
Business Mayor
14-05-2025
- Business
- Business Mayor
Be Clinical raises Rs 2 crore seed round led by Titan Capital
Be Clinical, a science-first skincare brand specialising in advanced anti-ageing solutions, today announced the successful closure of its Rs 2 crore seed funding round. The round was led by Titan Capital, with participation from Aditya Agarwal, Founder of P-TAL. With this funding, Be Clinical aims to accelerate its mission of providing advanced, targeted anti-ageing solutions and set new benchmarks for quality and transparency in skincare. Founded by Hemangi Dhir, Be Clinical was established as a result of her personal experience with persistent dermatological concerns that conventional products failed to address. Motivated by this challenge, she pursued a scientific approach to skincare, formulating precise and effective solutions that rapidly garnered recognition through word-of-mouth. This led to the creation of Be Clinical-a brand dedicated to delivering targeted, results-driven anti-ageing solutions rooted in both nature and clinical science. The newly secured funding will enable Be Clinical to internalise its manufacturing operations, thereby ensuring enhanced oversight of inventory, increased operational efficiency, and robust protection of proprietary formulations. This strategic initiative will also facilitate the brand's entry into additional anti-ageing segments, expanding its portfolio of clinically validated solutions focused on skin longevity. 'Securing this investment is a strong validation of our vision. Anti-ageing has often been treated as an afterthought in skincare, but at Be Clinical, it's our primary focus. We're building a brand that addresses a real and growing need-especially among Indian Gen Z and Millennial consumers, who are now seeking targeted, effective solutions earlier in their skincare journey. I feel incredibly optimistic about the future and confident that Be Clinical will set a new standard for science-first, results-driven skincare in India,' said Hemangi Dhir, Founder of Be Clinical, in a statement.
Time of India
14-05-2025
- Health
- Time of India
Be Clinical raises Rs 2 crore seed round led by Titan Capital
Be Clinical, a science-first skincare brand specialising in advanced anti-ageing solutions, today announced the successful closure of its Rs 2 crore seed funding round. The round was led by Titan Capital , with participation from Aditya Agarwal, Founder of P-TAL. With this funding, Be Clinical aims to accelerate its mission of providing advanced, targeted anti-ageing solutions and set new benchmarks for quality and transparency in skincare. Founded by Hemangi Dhir, Be Clinical was established as a result of her personal experience with persistent dermatological concerns that conventional products failed to address. Motivated by this challenge, she pursued a scientific approach to skincare, formulating precise and effective solutions that rapidly garnered recognition through word-of-mouth. This led to the creation of Be Clinical-a brand dedicated to delivering targeted, results-driven anti-ageing solutions rooted in both nature and clinical science. The newly secured funding will enable Be Clinical to internalise its manufacturing operations, thereby ensuring enhanced oversight of inventory, increased operational efficiency, and robust protection of proprietary formulations. This strategic initiative will also facilitate the brand's entry into additional anti-ageing segments, expanding its portfolio of clinically validated solutions focused on skin longevity. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The 18 Most Beautiful Hotel Swimming Pools You'll Wish You Could Dive Into! Learn More Undo 'Securing this investment is a strong validation of our vision. Anti-ageing has often been treated as an afterthought in skincare, but at Be Clinical, it's our primary focus. We're building a brand that addresses a real and growing need-especially among Indian Gen Z and Millennial consumers, who are now seeking targeted, effective solutions earlier in their skincare journey. I feel incredibly optimistic about the future and confident that Be Clinical will set a new standard for science-first, results-driven skincare in India,' said Hemangi Dhir, Founder of Be Clinical, in a statement.
Entrepreneur
13-05-2025
- Business
- Entrepreneur
Be Clinical, LUZO Raise Early-Stage Capital to Transform Skincare and Wellness Sectors
The following startups have announced their latest funding rounds. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Be Clinical Raises INR 2 Cr Seed Round from Titan Capital Be Clinical, a science-backed skincare brand, has raised INR 2 crore in a seed funding round led by Titan Capital, with additional participation from Aditya Agarwal, Founder of P-TAL. The funds will be used to internalise manufacturing, enhance inventory control, and expand the brand's portfolio of clinically validated anti-ageing products. Founded by Hemangi Dhir, Be Clinical was born from her personal struggle with stubborn dermatological issues that traditional products couldn't resolve. Her solution: a clinical, science-first skincare approach focused on targeted, results-driven anti-ageing treatments. "Securing this investment is a strong validation of our vision," said Dhir. "Anti-ageing is our core, not a footnote. We're building a brand rooted in science, transparency, and long-term trust for the modern Indian skincare consumer." Be Clinical offers medical-grade, efficacious formulations designed to protect, correct, and optimise skin health at every life stage. With a commitment to innovation and clinical integrity, the brand aims to meet the growing demand among Gen Z and Millennials for early, effective anti-ageing care. "We invested because Be Clinical bridges science and self-care with credibility," said a Titan Capital spokesperson. "Hemangi's insight into today's consumer and her commitment to high-performance skincare stood out." With this funding, Be Clinical is set to transform India's anti-ageing skincare landscape. LUZO Raises USD 550K Seed Round Led by ENRISSION INDIA CAPITAL LUZO, a curated digital marketplace for salons, spas, and wellness clinics, has raised USD 550K in a seed round led by ENRISSION INDIA CAPITAL. The round saw participation from notable investors, including the founders of Swiggy Dineout and Orra. The funds will be used to enhance LUZO's technology, expand its partner network across Tier-I cities, and boost brand visibility. Founded by Anurav Dave, Nikhil Kalwani, and Maan Jetley, LUZO is redefining how Indian consumers discover and book beauty and wellness services. With increasing demand for premium, tech-enabled self-care experiences among India's young, urban population, LUZO offers a seamless platform to explore, compare, and schedule appointments with verified providers. "Our goal is to make luxury wellness more accessible and frictionless," said Anurav Dave. "This investment supports our next phase of growth as we scale across cities and enhance the user experience through innovation." "LUZO's model is grounded in clear market demand, user-first design, and efficient execution," added Harsh Deordhar, Principal at ENRISSION INDIA CAPITAL. "It is poised to lead India's digital transformation in beauty and wellness." With this funding, LUZO is set to shape the future of wellness in India by merging convenience, credibility, and curated luxury.
